Our Approach
Focusing on providing the right systems to accelerate IO drug research
HLA-matched CTL and tumor lines, patient -derived samples and other tumors
View Our Cells
A complimentary chain of 2D, 3D and in vivo model systems for rapid translation
View Our Platforms
Scientific, clinical and technical expertise to access next-gen innovation and platforms.
View Our Approach#WorldCancerDay #Immune3D #Immunaccel
February 5, 2018 via @immunaccelImmune3D- unique platform to study immune-tumor interactions. #immune3d #JPM18
January 10, 2018 via @immunaccel#scheduledassays #JPM18 #immunaccel #JPM2018
January 8, 2018 via @immunaccelImmunaccel launches Scheduled Assay and Build an Assay programs https://t.co/Q1VRczTh7V
October 27, 2017 via @immunaccelImproving immuno-oncology with electronics-inspired gene 'circuits' | FierceBiotech https://t.co/BumUMPqMkX
October 24, 2017 via @immunaccelStudy unveils T cell signaling process central to immune response - Science Magazine https://t.co/kIYmWZZp5j
September 16, 2017 via @immunaccelOur immune system could cure cancer - Health Minute https://t.co/JRXEslhnJ9
September 9, 2017 via @immunaccel#AACR17 Excellent discussions on resistance mechanisms in the TME yesterday. # 3D tumor immune systems. https://t.co/X6wPUx9XlH
April 4, 2017 via @immunaccel#AACR17 Very cool. The nexus of checkpoint+stroma+ metabolic factors in the TME #3D immune models https://t.co/SjPQWh5t5w
April 2, 2017 via @immunaccelIt would interesting to study inflammation markers and gut pathogens in a 3D system#3D systems #paired colon lines
April 2, 2017 via @immunaccel#AACR17 Important role of the stroma and TME in studying immuno therapies and immune cells #3D systems https://t.co/WuKk6hhIbT
April 1, 2017 via @immunaccel